[
  {
    "trial_id": "EUCTR2023-501234-11-GB",
    "title": "Phase 3 Study of Novel Alzheimer's Treatment in European Population",
    "description": "A multicenter, randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of a novel monoclonal antibody in patients with early Alzheimer's disease across multiple European countries.",
    "status": "recruiting",
    "phase": "Phase 3",
    "sponsor": "European Pharma Consortium",
    "conditions": ["Alzheimer Disease", "Dementia", "Cognitive Impairment"],
    "interventions": ["Monoclonal Antibody Treatment", "Placebo"],
    "locations": [
      {
        "facility": "Charité - Universitätsmedizin Berlin",
        "city": "Berlin",
        "country": "Germany",
        "status": "Recruiting"
      },
      {
        "facility": "Hôpital de la Pitié-Salpêtrière",
        "city": "Paris",
        "country": "France",
        "status": "Recruiting"
      },
      {
        "facility": "Hospital Clínic de Barcelona",
        "city": "Barcelona",
        "country": "Spain",
        "status": "Recruiting"
      }
    ],
    "eligibility_criteria": {
      "gender": "All",
      "minAge": "50 Years",
      "maxAge": "85 Years",
      "criteria": "Inclusion: Clinical diagnosis of mild cognitive impairment or mild dementia due to Alzheimer's disease"
    },
    "source": "euctr",
    "compensation": {
      "amount": 2000,
      "currency": "EUR",
      "per_visit": 150,
      "visits_estimated": 12
    }
  },
  {
    "trial_id": "CTIS-2024-123456-BE",
    "title": "Advanced CAR-T Cell Therapy for Pediatric Leukemia",
    "description": "First-in-human study of next-generation CAR-T cell therapy for children with relapsed/refractory acute lymphoblastic leukemia.",
    "status": "recruiting",
    "phase": "Phase 1/2",
    "sponsor": "Belgian Cancer Institute",
    "conditions": ["Acute Lymphoblastic Leukemia", "Pediatric Cancer", "Blood Cancer"],
    "interventions": ["CAR-T Cell Therapy", "Standard Chemotherapy"],
    "locations": [
      {
        "facility": "University Hospitals Leuven",
        "city": "Leuven",
        "country": "Belgium",
        "status": "Recruiting"
      },
      {
        "facility": "Erasmus MC",
        "city": "Rotterdam",
        "country": "Netherlands",
        "status": "Not yet recruiting"
      }
    ],
    "eligibility_criteria": {
      "gender": "All",
      "minAge": "3 Years",
      "maxAge": "18 Years",
      "criteria": "Inclusion: Relapsed or refractory B-cell ALL, adequate organ function"
    },
    "source": "ctis",
    "compensation": {
      "amount": 0,
      "description": "All treatment costs covered, travel expenses reimbursed"
    }
  },
  {
    "trial_id": "ChiCTR2400012345",
    "title": "Traditional Chinese Medicine Combined with Modern Treatment for Long COVID",
    "description": "Investigating the efficacy of integrated traditional Chinese medicine approaches in managing post-COVID-19 syndrome symptoms.",
    "status": "recruiting",
    "phase": "Phase 2",
    "sponsor": "Beijing University of Chinese Medicine",
    "conditions": ["Post-Acute COVID-19 Syndrome", "Long COVID", "Chronic Fatigue"],
    "interventions": ["TCM Herbal Formula", "Acupuncture", "Standard Care"],
    "locations": [
      {
        "facility": "Beijing Hospital of Traditional Chinese Medicine",
        "city": "Beijing",
        "country": "China",
        "status": "Recruiting"
      },
      {
        "facility": "Guangdong Provincial Hospital",
        "city": "Guangzhou",
        "country": "China",
        "status": "Recruiting"
      }
    ],
    "eligibility_criteria": {
      "gender": "All",
      "minAge": "18 Years",
      "maxAge": "70 Years",
      "criteria": "Inclusion: Persistent symptoms 3+ months after COVID-19 infection"
    },
    "source": "chictr",
    "compensation": {
      "amount": 3000,
      "currency": "CNY",
      "per_visit": 200
    }
  },
  {
    "trial_id": "JPRN-jRCT2031240567",
    "title": "Regenerative Medicine Trial for Spinal Cord Injury",
    "description": "Phase 2 study of induced pluripotent stem cell therapy for patients with chronic spinal cord injury.",
    "status": "recruiting",
    "phase": "Phase 2",
    "sponsor": "Kyoto University Hospital",
    "conditions": ["Spinal Cord Injury", "Paralysis", "Neurological Disorders"],
    "interventions": ["iPSC-derived Neural Progenitor Cells", "Rehabilitation Therapy"],
    "locations": [
      {
        "facility": "Kyoto University Hospital",
        "city": "Kyoto",
        "country": "Japan",
        "status": "Recruiting"
      },
      {
        "facility": "Keio University Hospital",
        "city": "Tokyo",
        "country": "Japan",
        "status": "Recruiting"
      }
    ],
    "eligibility_criteria": {
      "gender": "All",
      "minAge": "18 Years",
      "maxAge": "65 Years",
      "criteria": "Inclusion: Chronic SCI (>6 months), ASIA grade B or C"
    },
    "source": "jprn",
    "compensation": {
      "amount": 500000,
      "currency": "JPY",
      "description": "All medical expenses covered plus compensation"
    }
  },
  {
    "trial_id": "ACTRN12624000123506",
    "title": "Indigenous Health Study: Diabetes Prevention in Aboriginal Communities",
    "description": "Community-based intervention trial for Type 2 diabetes prevention in Australian Aboriginal and Torres Strait Islander peoples.",
    "status": "recruiting",
    "phase": "N/A",
    "sponsor": "Australian National University",
    "conditions": ["Type 2 Diabetes", "Obesity", "Metabolic Syndrome"],
    "interventions": ["Community Health Program", "Lifestyle Intervention", "Standard Care"],
    "locations": [
      {
        "facility": "Alice Springs Hospital",
        "city": "Alice Springs",
        "state": "Northern Territory",
        "country": "Australia",
        "status": "Recruiting"
      },
      {
        "facility": "Cairns Hospital",
        "city": "Cairns",
        "state": "Queensland",
        "country": "Australia",
        "status": "Recruiting"
      }
    ],
    "eligibility_criteria": {
      "gender": "All",
      "minAge": "18 Years",
      "maxAge": "N/A",
      "criteria": "Inclusion: Aboriginal or Torres Strait Islander, at risk for diabetes"
    },
    "source": "anzctr",
    "compensation": {
      "amount": 200,
      "currency": "AUD",
      "per_visit": 50,
      "description": "Compensation for time and travel"
    }
  }
]